Undiagnosed polyarthritis with positive anti-Ro/SSA antibodies following a biliopancreatic bypass for morbid obesity

1996 ◽  
Vol 15 (5) ◽  
pp. 514-515 ◽  
Author(s):  
A. Zoli ◽  
L. Altomonte ◽  
A. Serra ◽  
G. C. Santacesaria ◽  
R. Caricchio ◽  
...  
Keyword(s):  
Morbid Obesity ◽  
Biliopancreatic Bypass

scholarly journals Case of insulinoma detected in a patient after bariatric operation for morbid obesity

2019 ◽  
Vol 16 (1) ◽  
pp. 74-80
Author(s):  
Ekaterina S. Maloletkina ◽  
Olesya Y. Gurova ◽  
Valentin V. Fadeyev ◽  
Vyacheslav I. Egorov ◽  
Roman V. Petrov ◽  
...  
Keyword(s):  
Morbid Obesity ◽  
Weight Gain ◽  
Surgical Treatment ◽  
Successful Treatment ◽  
Clinical Case ◽  
Bariatric Operation ◽  
Malignant Insulinoma ◽  
Biliopancreatic Bypass ◽  
Longitudinal Gastrectomy

The prevalence of insulinomas is 13 cases per million population per year of which 414% tumor is malignant. Weight gain is one of the symptoms of the disease, often resulting in morbid obesity with indications for surgical treatment. The presented clinical case demonstrates the successful treatment of malignant insulinoma with the manifestation of hypoglycemic syndrome after carrying out biliopancreatic bypass with longitudinal gastrectomy for morbid obesity.

Small-Intestinal and Colonic Changes after Biliopancreatic Bypass for Morbid Obesity

1986 ◽  
Vol 21 (9) ◽  
pp. 1115-1123 ◽  
Author(s):  
C. Stock-damgé ◽  
M. Aprahamian ◽  
F. Raul ◽  
J. Marescaux ◽  
N. Scopinaro
Keyword(s):  
Morbid Obesity ◽  
Biliopancreatic Bypass ◽  
Small Intestinal

Modifications in food intake, leptin and CCK postprandial levels after Gastric Banding for morbid obesity

2001 ◽  
Vol 120 (5) ◽  
pp. A209-A209
Author(s):  
M LUCA ◽  
E CERVELLIN ◽  
F GALEAZZI ◽  
D LANARO ◽  
L BUSETTO ◽  
...  
Keyword(s):  
Morbid Obesity ◽  
Food Intake ◽  
Gastric Banding

1596: Does Morbid Obesity Affect Operative Parameters, Complications, or Oncologic Outcomes after Robot-Assisted Radical Prostatectomy?

2007 ◽  
Vol 177 (4S) ◽  
pp. 528-528
Author(s):  
Seth A. Capello ◽  
Judd Boczko ◽  
Hitendra R.H. Patel ◽  
Jean V. Joseph
Keyword(s):  
Morbid Obesity ◽  
Radical Prostatectomy ◽  
Oncologic Outcomes ◽  
Robot Assisted

Jejunoileal bypass as a treatment of morbid obesity

1977 ◽  
Vol 137 (5) ◽  
pp. 602-610 ◽  
Author(s):  
J. M. Campbell
Keyword(s):  
Morbid Obesity ◽  
Jejunoileal Bypass

Serum Retinol and β-carotene Levels and Risk Factors for Cardiovascular Disease in Morbid Obesity

2010 ◽  
Vol 80 (3) ◽  
pp. 159-167 ◽  
Author(s):  
Gabriela Villaça Chaves ◽  
Gisele Gonçalves de Souza ◽  
Andréa Cardoso de Matos ◽  
Dra. Wilza Abrantes Peres ◽  
Silvia Elaine Pereira ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Metabolic Syndrome ◽  
Morbid Obesity ◽  
Serum Levels ◽  
World Health ◽  
Morbidly Obese ◽  
Serum Retinol ◽  
Significant Difference ◽  
Β Carotene

Objective: To evaluate retinol and β-carotene serum levels and their relationship with risk factors for cardiovascular disease in individuals with morbid obesity, resident in Rio de Janeiro. Methodology: Blood serum concentrations of retinol and β-carotene of 189 morbidly obese individuals were assessed. The metabolic syndrome was identified according to the criteria of the National Cholesterol Education Program (NCEP) and World Health Organization (WHO). Lipid profile, insulin resistance, basal insulin, glycemia, blood pressure, and anthropometry and their correlation with retinol and β-carotene serum levels were evaluated. Results: Metabolic syndrome diagnosis was observed in 49.0% of the sample. Within this percentage the levels of β-carotene were significantly lower when body mass index increased. Serum retinol didn't show this behavior. Serum retinol inadequacy in patients with metabolic syndrome (61.3%), according to WHO criterion, was higher (15.8%) than when the whole sample was considered (12.7%). When metabolic syndrome was diagnosed by NCEP criterion, β-carotene inadequacy was higher (42.8%) when compared to the total sample (37.5%). There was a significant difference between average β-carotene values of patients with and without metabolic syndrome (p=0.048) according to the classification of the NCEP. Lower values were found in patients with metabolic syndrome. Conclusion: Considering the vitamin A contribution in antioxidant protection, especially when risk factors for cardiovascular disease are present, it is suggested that great attention be given to morbidly obese. This could aid in prevention and treatment of cardiovascular disease, which affects a significant part of the population.

Prevalence of insulin resistance in morbid obesity in young Europeans

2004 ◽  
Vol 29 (05) ◽  
Author(s):  
D Weghuber ◽  
M Roden ◽  
A Tura ◽  
G Pacini ◽  
M Bischof ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Morbid Obesity

Early noninvasive diagnostic of ischemic heart disease in the patient with metabolic syndrome, morbid obesity and intraventricular disturbances

2015 ◽  
pp. 70-79
Author(s):  
Irina Polyakova ◽  
◽  
Tat'yana Feofanova ◽  
Al'fred Bogdanov ◽  
Svetlana Derbeneva ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Morbid Obesity ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Ischemic Heart
Sign in / Sign up

Export Citation Format

Share Document